Veradigm | Le Bénéfice D'Exploitation



Le Bénéfice D'Exploitation Changement Date
Alcidion AUD 444K 1.55M 2025-06
Ambu A/S DKK 164M 17M 2025-12
Amplifon EUR 24.29M 45.59M 2025-09
Cardinal Health USD 763M 9M 2025-12
Centene USD -1.23B 1.03B 2025-12
Charles River Laboratories USD 133.8M 1.46M 2025-09
Cigna USD 2.75B 240M 2025-09
Convatec Group USD 175.7M 101.1M 2024-12
CVS Health USD 2.11B 836M 2025-12
Diasorin EUR 56.68M 18.65M 2025-09
Elevance Health USD 581M 1.18B 2025-12
General Electric Aerospace USD 1.77B 536M 2025-12
Gulf Medical Proj AED 14.87M 16.62M 2025-06
Humana USD -808M 1.21B 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 397.3M 65.5M 2025-09
Maximus USD 146.21M 23.35M 2025-12
McKesson USD 1.66B 159M 2025-12
Med Life RON 40.09M 1.45M 2025-09
Molina Healthcare USD -153M 293M 2025-12
Omnicell USD 1.18M 9.81M 2025-12
Oriola-kd EUR 6.6M 8M 2025-09
Owens Minor USD 56.75M 56.63M 2025-06
Quest Diagnostics USD 386M 0 2025-12
Rede D'or Sao Luiz BRL 2.73B 475.99M 2025-09
Siemens Healthineers EUR 677M 214M 2025-12
Sonova Holding CHF 296.8M 156.9M 2025-12
Supermax Corporation Bhd MYR -143.15M 38.31M 2025-09
UnitedHealth USD 3.26B 1.06B 2025-12
Veeva Systems USD 240.85M 14.32M 2025-09
Xerox USD 30M 48M 2025-06


Veradigm Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.